Surgery Partners Inc (FRA:1SP)
€ 12.8 -0.30 (-2.29%) Market Cap: 1.69 Bil Enterprise Value: 6.57 Bil PE Ratio: 0 PB Ratio: 1.16 GF Score: 65/100

Q3 2025 Surgery Partners Inc Earnings Call Transcript

Nov 10, 2025 / 01:30PM GMT
Release Date Price: €18.4 (+0.55%)

Key Points

Positve
  • Surgery Partners Inc (SGRY) reported a 6.6% year-over-year increase in net revenue for the third quarter, reaching $821.5 million.
  • The company achieved a 6.1% year-over-year growth in adjusted EBITDA, amounting to $136.4 million, with a stable margin of 16.6%.
  • Same facility revenue grew by 6.3%, driven by strong performance in gastrointestinal and musculoskeletal procedures, particularly in orthopedics.
  • Surgery Partners Inc (SGRY) has successfully recruited over 500 new physicians year-to-date, enhancing its capacity to meet high acuity demand.
  • The company has a robust M&A pipeline with over $300 million in opportunities under active evaluation, indicating potential for future growth.
Negative
  • The payer mix shifted unfavorably, with commercial payers representing a smaller portion of revenues, impacting margins.
  • Surgery Partners Inc (SGRY) experienced softer-than-expected same-facility volume growth, prompting a revision of its fourth-quarter outlook.
  • The company has not yet redeployed proceeds from divestitures, contributing to a revised guidance for the full year.
  • There were construction and regulatory delays affecting the ramp-up of new de novo facilities, creating near-term pressure on earnings.
  • The company revised its full-year guidance, now expecting revenue between $3.275 billion and $3.3 billion, and adjusted EBITDA between $535 million and $540 million, reflecting timing-related impacts and a cautious outlook on commercial payer mix.
Operator

Greetings, and welcome to the Surgery Partners' third-quarter 2025 earnings call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Dave Doherty. Please go ahead.

David Doherty
Surgery Partners Inc - Chief Financial Officer, Executive Vice President

Good morning, and thank you for joining Surgery Partners' third-quarter 2025 earnings call. I am joined today by Eric Evans, our CEO. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements as described in this morning's press release and the reports we file with the SEC, each of which are available on our corporate website. The company does not undertake any duty to update these forward-looking statements.

In addition, we reference certain financial measures that are non-GAAP, which we believe can be useful in evaluating our performance. We reconcile these measures to the most applicable GAAP measure in this morning's press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot